Építés alatt – nem éles oldal
Belépés
Résztvevőt keresFázis nélkül

INFLATE Study: Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis

A legfontosabb adatok

Ki végzi
Biosensors Europe SA
Hol
Spanyolország9 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toboroz
Résztvevők
93 fő, tervezett
Kezdés
2025. dec. 15.
Tervezett befejezés
2026. aug.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • PTV (Percutaneous Transcatheter Valvuloplasty) Balloon
A regiszteradat frissítve
2026. április 16.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with severe, symptom-causing narrowing of the aortic heart valve due to calcium, who are planned for TAVI through the groin artery. A new balloon device (PTV Balloon) will be used to widen the valve during the procedure.

Életkor
18 years and older
Nem
All sexes can join
A betegség stádiuma
Symptomatic severe calcific aortic stenosis of the own (native) valve. Valve area ≤1.0 cm2 (or AVA index ≤0.6 cm2/m2) AND mean pressure gradient ≥ 40mmHg OR maximal velocity ≥4.0m/s OR Doppler velocity index ≤0.25 on heart ultrasound. The local Heart Team must agree that TAVI is the right procedure and that the person can have it. A trans-femoral (through the groin) procedure must be planned.
Korábbi kezelés
People with a permanent pacemaker cannot join.

A részvétel fő kizáró okai

  • Aortic annulus or bioprosthesis inner diameter <16 mm or >30 mm
  • Existing heart rhythm conduction problems (LBBB, RBBB, AV block 2 and 3) or a permanent pacemaker
  • Stroke or TIA within 6 months, heart attack within 30 days, or active infection such as endocarditis
  • Ejection fraction <20%, severe tricuspid or mitral leak, or kidney failure needing continuous renal replacement therapy
  • Pregnancy or plans to become pregnant, or taking part in another investigational study

A regiszter feltételei, szó szerint

Mind a 29 feltétel megnézéseKevesebb

Ki vehet részt

  • Symptomatic severe calcific stenosis of a native aortic valve with an AVA ≤1.0 cm2 (or AVA index ≤0.6 cm2/m2) AND mean aortic pressure gradient ≥ 40mmHg OR maximal transaortic velocity ≥4.0m/s OR Doppler velocity index ≤0.25 on site-reported echocardiography
  • Local multi-disciplinary Heart Team agrees on indication and eligibility for TAVI
  • Age ≥18 years
  • Patient has signed the Patient Informed Consent Form
  • Patient is willing and able to comply with requirements of the study
  • Patients planned for trans-femoral procedure

Ki nem vehet részt

  • Acute MI ≤30 days prior to the index procedure
  • Cerebrovascular accident (CVA) or transient ischemic attack (TIA) ≤6 months or prior CVA with moderate or severe disability (e.g. modified Rankin scale score >2)
  • Currently participating in another investigational drug or device study
  • Significant disease of the aorta that would preclude safe advancement of the TAVI system
  • Severe ilio-femoral vessel disease that would preclude safe performance of the TAVI procedure
  • Severe tricuspid regurgitation and/or failing right heart (site-reported)
  • Evidence of active endocarditis or other acute infections
  • Renal failure requiring continuous renal replacement therapy
  • Untreated clinically significant coronary artery disease requiring revascularization
  • Symptomatic carotid or vertebral artery disease requiring intervention or carotid/vertebral intervention within the preceding 45 days
  • Severe (greater than 3+) mitral insufficiency (site-reported)
  • Isolated Aortic Insufficiency
  • Severe left ventricular dysfunction with ejection fraction (EF) <20% (site-reported)
  • History of bleeding diathesis or coagulopathy; acute blood dyscrasias as defined: thrombocytopenia (platelets <80,000/µl), acute anemia (hemoglobin <10 g/dl), leukopenia (WBC <3000/ µl)
  • Known hypersensitivity to contrast media, which cannot be adequately pre-medicated or contraindication to anticoagulant or anti-platelet medication or to nitinol alloy or to bovine tissue
  • Mean aortic annulus diameter as measured by pre-procedural CT or internal diameter of the bioprosthesis is <16 mm or >30 mm
  • Echocardiographic evidence of intracardiac thrombus, mass or vegetation (site-reported)
  • Pregnancy or intend to become pregnant during study participation
  • Unicuspid aortic valve
  • Non-calcified aortic stenosis
  • Identified high risk of coronary occlusion due to Sinus of Valsalva anatomy and/or bulky calcified aortic valve leaflets in close proximity to coronary ostia
  • Patients with a permanent pacemaker
  • Patients with pre-existing LBBB, RBBB and AV block 2 and 3

Ez a vizsgálat jelenleg itt érhető el: Spanyolország.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

This clinical investigation is being done to evaluate the safety and effectiveness of a new device, a PTV Balloon, that will be used to open up an area in the heart (the valve) before and potentially after placing a new valve in patients requiring a new heart valve.

A teljes eredeti leírásKevesebb

The main question it aims to answer is:

What percentage of patients develop new heart conduction problems after using the investigational PTV Balloon for pre-dilatation?

Participants will:

1. Undergo a TAVI procedure, where the PTV Balloon will be used for pre-dilatation and may also be used for post-dilatation. 2. Will be followed up until discharge or up to 7 days, whichever happens first.

A vizsgálat csoportja

  • Biosensors PTV balloon catheterA vizsgált kezelés

    Patients suffering from a severe aortic stenosis and scheduled for a TAVI.

    Kezelés: PTV (Percutaneous Transcatheter Valvuloplasty) Balloon

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Investigation of the Safety and Performance of a Novel PTV Balloon in Patients Undergoing TAVI for Severe Aortic Stenosis
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. április 16.